{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T07:49:45Z","timestamp":1788508185560,"version":"build-2803163510"},"reference-count":21,"publisher":"The Japanese Society for Medical Mycology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Mycology Journal"],"published-print":{"date-parts":[[2025,10,31]]},"DOI":"10.3314\/mmj.25-00005","type":"journal-article","created":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T22:08:29Z","timestamp":1764454109000},"page":"165-170","source":"Crossref","is-referenced-by-count":1,"title":["Species Distribution and Antifungal Susceptibility of Fungal Blood Isolates over a 16-Year Period at a University Hospital"],"prefix":"10.3314","volume":"66","author":[{"given":"Shigeki","family":"Misawa","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory Technology, Juntendo University Faculty of Medical Science"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Chonan","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Juntendo University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Sano","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Juntendo University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gene","family":"Igawa","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Juntendo University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maika","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Juntendo University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Juntendo University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Nagasawa","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Juntendo University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Furusawa","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Juntendo University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayuri","family":"Otsuka","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Juntendo University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Souta","family":"Takeda","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Juntendo University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Kawakami","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Juntendo University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Wakita","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Juntendo University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Sasano","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Juntendo Tokyo Koto Geriatric Medical Center"},{"name":"Department of General Medicine, Juntendo University Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Juntendo University Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Tabe","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Juntendo University Hospital"},{"name":"Department of Clinical Laboratory Medicine, Juntendo University Faculty of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Miida","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory Technology, Juntendo University Faculty of Medical Science"},{"name":"Department of Clinical Laboratory Medicine, Juntendo University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1842","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Denning DW: Global incidence and mortality of severe fungal diseases. Lancet Infect Dis 24: e428&ndash;e38, 2024.","DOI":"10.1016\/S1473-3099(23)00692-8"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Koehler P, Stecher M, Cornely OA, Koehler D, Vehreschild MJGT, Bohlius J, et al: Morbidity and mortality of candidaemia in Europe: An epidemiologic meta-analysis. Clin Microbiol Infect 25: 1200&ndash;12, 2019.","DOI":"10.1016\/j.cmi.2019.04.024"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Pappas PG, Kauffman CA, Andes DR, Clancy CJ, Marr KA, Ostrosky-Zeichner L, et al: Clinical practice guideline for the management of candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis 62: e1&ndash;e50, 2016.","DOI":"10.1093\/cid\/civ933"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Pfaller MA, Diekema DJ, Turnidge JD, Castanheira M, Jones RN: Twenty years of the SENTRY antifungal surveillance program: Results for <i>Candida<\/i> species from 1997-2016. Open Forum Infect Dis 6: S79&ndash;S94, 2019.","DOI":"10.1093\/ofid\/ofy358"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Tan TY, Hsu LY, Alejandria MM, Chaiwarith R, Chinniah T, Chayakulkeeree M, et al: Antifungal susceptibility of invasive <i>Candida<\/i> bloodstream isolates from the Asia-Pacific region. Med Mycol 54: 471&ndash;7, 2016.","DOI":"10.1093\/mmy\/myv114"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Takakura S, Fujihara N, Saito T, Kudo T, Iinuma Y, Ichiyama S: National surveillance of species distribution in blood isolates of <i>Candida<\/i> species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin. J Antimicrob Chemother 53: 283&ndash;9, 2004.","DOI":"10.1093\/jac\/dkh053"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Morii D, Seki M, Binongo JN, Ban R, Kobayashi A, Sata M, et al: Distribution of <i>Candida<\/i> species isolated from blood cultures in hospitals in Osaka, Japan. J Infect Chemother 20: 558&ndash;62, 2014.","DOI":"10.1016\/j.jiac.2014.05.009"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Kakeya H, Yamada K, Kaneko Y, Yanagihara K, Tateda K, Maesaki S, et al: National trends in the distribution of <i>Candida<\/i> species causing candidemia in Japan from 2003 to 2014: A report by the Epidemiological Investigation Committee for Human Mycoses in Japan. Med Mycol J 59: E19&ndash;E22, 2018.","DOI":"10.3314\/mmj.17-00014"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Kajihara T, Yahara K, Nagi M, Kitamura N, Hirabayashi A, Hosaka Y, et al: Distribution, trends, and antifungal susceptibility of <i>Candida<\/i> species causing candidemia in Japan, 2010&ndash;2019: A retrospective observational study based on national surveillance data. Med Mycol 60: myac071, 2022.","DOI":"10.1093\/mmy\/myac071"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Arastehfar A, Gabald\u00f3n T, Garcia-Rubio R, Jenks JD, Hoenigl M, Salzer HJF, et al: Drug-resistant fungi: An emerging challenge threatening our limited antifungal armamentarium. Antibiotics (Basel) 9: 877, 2020.","DOI":"10.3390\/antibiotics9120877"},{"key":"11","unstructured":"11) Clinical and Laboratory Standards Institute: Reference method for broth dilution antifungal susceptibility testing of yeasts\u2013Third edition: Approved standard M27-A3. Clinical and Laboratory Standards Institute, USA, 2008."},{"key":"12","unstructured":"12) Clinical and Laboratory Standards Institute: Performance standards for antifungal susceptibility testing of yeasts, 3rd ed. CLSI supplement M27M44S. Clinical and Laboratory Standards Institute, USA, 2022."},{"key":"13","unstructured":"13) European Committee on Antimicrobial Susceptibility Testing: Breakpoint tables for interpretation of MICs for antifungal agents, version10.0, 2020."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Katsuragi S, Sata M, Kobayashi Y, Miyoshi T, Yamashita Y, Neki R, et al: Antifungal susceptibility of <i>Candida<\/i> isolates at one institution. Med Mycol J 55: E1&ndash;E7, 2014.","DOI":"10.3314\/mmj.55.E1"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Beyer R, Spettel K, Zeller I, Lass-Fl\u00f6rl C, Achleitner D, Krause R, et al: Antifungal susceptibility of yeast bloodstream isolates collected during a 10-year period in Austria. Mycoses 62: 357&ndash;67, 2019.","DOI":"10.1111\/myc.12892"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Astvad KMT, Johansen HK, R\u00f8der BL, Rosenvinge FS, Knudsen JD, Lemming L, et al: Update from a 12-year nationwide fungemia surveillance: Increasing intrinsic and acquired resistance causes concern. J Clin Microbiol 56: e01564-17, 2018.","DOI":"10.1128\/JCM.01564-17"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Xiao M, Chen SC-A, Kong F, Xu X-L, Yan L, Kong H-S, et al: Distribution and antifungal susceptibility of <i>Candida<\/i> species causing candidemia in China: An update from the CHIF-NET study. J Infect Dis 221: S139&ndash;S47, 2020.","DOI":"10.1093\/infdis\/jiz573"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Memon S, Farooqi J, Zafar U, Naqvi SF, Zafar A, Jabeen K: Antifungal susceptibility profile of invasive <i>Candida glabrata<\/i> isolates (2009-2020) from a tertiary care hospital laboratory in Pakistan. J Med Microbiol 70: 001459, 2021.","DOI":"10.1099\/jmm.0.001459"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Govender NP, Patel J, Magobo RE, Naicker S, Wadula J, Whitelaw A, et al: Emergence of azole-resistant <i>Candida parapsilosis<\/i> causing bloodstream infection: Results from laboratory-based sentinel surveillance in South Africa. J Antimicrob Chemother 71: 1994&ndash;2004, 2016.","DOI":"10.1093\/jac\/dkw091"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Favarello LM, Nucci M, Queiroz-Telles F, Guimar\u00e3es T, Salles MJ, Sukiennik TCT, et al: Trends towards lower azole susceptibility among 200 <i>Candida tropicalis<\/i> bloodstream isolates from Brazilian medical centers. J Grob Antimicrob Resist 25: 199&ndash;201, 2021.","DOI":"10.1016\/j.jgar.2021.03.018"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Healey KR, Perlin DS: Fungal resistance to echinocandins and the MDR phenomenon in <i>Candida glabrata<\/i>. J Fungi (Basel) 4: 105, 2018.","DOI":"10.3390\/jof4030105"}],"container-title":["Medical Mycology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mmj\/66\/4\/66_165\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T04:35:48Z","timestamp":1764995748000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/mmj\/66\/4\/66_165\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.3314\/mmj.25-00005","relation":{},"ISSN":["2185-6486","2186-165X"],"issn-type":[{"value":"2185-6486","type":"print"},{"value":"2186-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]}}}